RSAD2
RSAD2 (radical S-adenosyl methionine domain containing 2), also known as Viperin, cig5 and vig1, is an interferon-inducible antiviral enzyme of the radical SAM superfamily. It converts CTP into the chain-terminating nucleotide ddhCTP and contributes to innate immune signalling. Browse Assay Genie's current range of RSAD2 research reagents below, or read on for the biology behind the target.
RSAD2 is an interferon-inducible antiviral protein that plays a major role in the cellular antiviral state induced by type I and type II interferon. It catalyses the conversion of cytidine triphosphate (CTP) to 3'-deoxy-3',4'-didehydro-CTP (ddhCTP) through a SAM-dependent radical mechanism. ddhCTP acts as a chain terminator for the RNA-dependent RNA polymerases of multiple viruses and directly inhibits viral replication. As a result, RSAD2 restricts a wide range of DNA and RNA viruses, including human cytomegalovirus, hepatitis C virus, West Nile virus, dengue virus, Sindbis virus, influenza A virus, Sendai virus, vesicular stomatitis virus, Zika virus and HIV-1.
Beyond direct antiviral activity, the RSAD2 protein shapes immune signalling. It promotes TLR7- and TLR9-dependent production of IFN-beta in plasmacytoid dendritic cells by facilitating 'Lys-63'-linked ubiquitination of IRAK1 by TRAF6. It also contributes to CD4+ T-cell activation and differentiation, supporting T-cell receptor-mediated GATA3 activation and optimal T-helper 2 cytokine production by modulating NFKB1 and JUNB activities. NCBI Gene summarises further antiviral mechanisms, including interference in the secretory pathway, binding to viral proteins and dysregulation of cellular lipid metabolism, and UniProt notes that it can inhibit secretion of soluble proteins.
The RSAD2 gene belongs to the radical SAM superfamily and the RSAD2 family, and HGNC places it in the radical S-adenosylmethionine domain containing and carbon-oxygen lyase gene groups. UniProt records the protein at the endoplasmic reticulum membrane, Golgi apparatus, lipid droplets and mitochondria, including the inner and outer mitochondrial membranes. Mouse and rat both carry an orthologous Rsad2 gene. The symbol cig5 and the name Viperin are used in the literature alongside vig1.
RSAD2 is induced by type I and type II interferon and restricts many DNA and RNA viruses, making it a key readout of the interferon response.
RSAD2 converts CTP to ddhCTP, a chain terminator of viral RNA-dependent RNA polymerases, opening study of radical SAM chemistry in host defence.
RSAD2 promotes IFN-beta production in plasmacytoid dendritic cells by supporting TRAF6-mediated Lys-63-linked ubiquitination of IRAK1.
RSAD2 supports TCR-mediated GATA3 activation and Th2 cytokine production in CD4+ T-cells through effects on NFKB1 and JUNB.
RSAD2 is an interferon-inducible radical SAM enzyme that converts CTP to ddhCTP, a chain terminator for viral RNA-dependent RNA polymerases. It also promotes IFN-beta production in plasmacytoid dendritic cells and contributes to CD4+ T-cell activation and Th2 cytokine production.
RSAD2 is also called Viperin, cig5 and vig1. UniProt lists the protein name S-adenosylmethionine-dependent nucleotide dehydratase RSAD2, and HGNC gives the full gene name as radical S-adenosyl methionine domain containing 2. Check the datasheet of any product for its validated reactivity.
Yes. Mouse and rat each have an orthologous gene named Rsad2. The human RSAD2 gene sits at 2p25.2 and encodes a protein of the radical SAM superfamily. Check the datasheet of any product for its validated reactivity.
Interferon-response proteins, TLR signalling components and T-cell transcription factors connected to RSAD2 biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WXG1; product specifications from Assay Genie datasheets.